UiPath is trading 10% down at $16.40 in pre-market after investors sold shares following its September 3 earnings report. * Q2 revenue reached $410.3 million, while ARR rose 12% to $1.938 billion. * Management raised its full-year outlook and emphasized its pivot toward agentic AI. * The decline is attributed to a "sell-the-news" reaction, compounded by multiple analyst downgrades on September 4, 2026, and a leadership transition.